This July 15, 2011, file photo shows Clorox brand products line the shelf of a supermarket in the East Village neighborhood of New York. A handful of companies are rising to new highs even as stock markets around the world tumble on worries about a rapidly spreading virus. Clorox is close to an all-time high after jumping Monday, Feb. 24, 2020, amid expectations that more homes and hospitals will use its disinfecting wipes, for example. (AP Photo/Mary Altaffer, File)
NEW YORK (AP) — Stay indoors and stay clean. That's what Wall Street is betting people around the world will do given all the fears about a rapidly spreading virus.
As stock markets tumble on worries about how much COVID-19 will harm people and slow the global economy, more than a handful of companies have nevertheless been rising to new highs. They cross a range of industries, but in each of them investors see a chance to make money off fears about the virus.
Clorox is close to an all-time high after jumping Monday amid expectations that homes and hospitals will use more of its disinfecting wipes, for example. Zoom Video Communications, which lets people conduct meetings online instead of in person, has surged nearly 40% in five weeks on the belief that people want to avoid getting within coughing range. A host of vaccine makers have shot higher on hopes that they may come up with something to corral the new virus.
In some cases, analysts say the moves are overdone. Medical experts still can't say how far and how quickly the virus will spread. The rapidly rising numbers of cases outside the viral outbreak's center in China sent the S&P 500 on Monday to its worst day in more than two years. The index is down about 3.1% since Jan. 17, when the market set a new high before worries about the virus began to crescendo.
The vaccine makers are particularly speculative bets because there's no guarantee they'll come up with anything. But that's not keeping Wall Street from looking for potential winners. Here's a look at a few:
— (SOME) HEALTH COMPANIES
As a group, health care stocks in the S&P 500 are down more than the index since Jan. 17, 4.4% versus 3.1%. But Gilead Sciences is an outlier, up 15.8% over the same time. The company is working on a treatment for the new virus, named Remdesivir, though it has not been approved anywhere globally for use.
Several other, smaller vaccine makers have shot even higher over the same period on similar hopes. Novavax, whose $258 million market value is about a quarter of 1% of Gilead's size, is up 42% since Jan. 17.
— COMPANIES THAT HELP PEOPLE WORK OR STAY AT HOME
Zoom Video Communications stock touched $110 during Monday's trading, a level it's reached just once since its shares began trading last spring. The company has said it's seeing more business from customers wanting to meet online.
Zoom CEO Eric Yuan went on CNBC earlier this month to say that “everyone is calling us” and usage has been at record levels. Stephens analyst Ryan MacWilliams says the boost in Zoom shares is indeed likely due to being “a play on” the virus outbreak. Summit Insights Group analyst Jonathan Kees, though, cautions that any benefit the company sees from the virus will be “incremental.”
Streaming video services could also be a beneficiary as people look to stay away from crowds. Netflix, which is up 8.5% since Jan. 17, and other streaming video companies could benefit “from even the thought of COVID-19, much less its actual arrival and any restrictions that it will usher in,” said Forrester analyst James McQuivey. He called the virus “a mild accelerant” for such digital entertainment services.
— GOLD MINERS
When fear is gripping markets, investors often run toward gold in a self-fulfilling prophecy. The metal has a reputation for holding up during tumultuous times, which increases demand for it just when such conditions occur. Gold on Monday jumped again to reach a seven-year high. That in turn has helped vault shares of gold miners higher, and Newmont Mining has added nearly 16% since Jan. 17.
— COMPANIES THAT PAY DIVIDENDS
Only two of the 11 sectors that make up the S&P 500 index are higher since Jan. 17: utilities and real-estate investment trusts, both of which have climbed more than 4%. It's not because the virus will make anyone buy more electricity or office buildings but because these kinds of companies pay healthy dividends at a time when bond yields are plunging.
Investors have been rushing to buy U.S. government bonds along with gold in their search for safety. When a bond's price rises, its yield falls, and the 10-year Treasury's yield has sunk to 1.36% from roughly 1.90% at the start of the year. Such meager yields make the 3% dividend yields paid by the average utility or real-estate stock more attractive to investors looking for income. ___
AP Business Writer Tali Arbel contributed.
15 Technology Stocks that Analysts Love
There are more than 1,100 technology companies traded on public markets in the United States. Given the sheer number of hardware makers, social networks, software companies, service providers and other tech stocks, it can be hard to identify which tech companies are going to outperform the market.
Fortunately, Wall Street's brightest minds have already done this for us. Every year, analyst issue approximately 15,000 distinct recommendations for technology companies. Analysts don't always get their "buy" ratings right, but it's worth taking a hard look when several analysts from different brokerages and research firm are giving "strong buy" and "buy" ratings to the same tech stock.
This slide show lists the 15 technology companies that have the highest average analyst recommendations from Wall Street's equities research analysts over the last 12 months.
View the "15 Technology Stocks that Analysts Love".